Results 1 to 10 of about 242,918 (218)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology [PDF]

Clinical and Developmental Immunology, 2011
Stereotactic radiation approaches are gaining more popularity for the treatment of intracranial as well as extracranial tumors in organs such as the liver and lung.
Steven Eric Finkelstein, Robert Timmerman, William H. McBride, Dörthe Schaue, Sarah E. Hoffe, Constantine A. Mantz, George D. Wilson   +6 more
doaj   +7 more sources

Advances in Radiobiology of Stereotactic Ablative Radiotherapy

Frontiers in Oncology, 2020
Radiotherapy (RT) has been developed with remarkable technological advances in recent years. The accuracy of RT is dramatically improved and accordingly high dose radiation of the tumors could be precisely projected.
Junjie Wang, Ping Jiang, Bin Qiu
exaly   +5 more sources

Stereotactic ablative radiotherapy for primary renal cell carcinoma [PDF]

Clinical and Translational Radiation Oncology
Stereotactic ablative radiotherapy (SAbR) is an emerging non-invasive definitive treatment option for primary renal cell carcinoma (RCC), particularly when surgery is not ideal.
Daniel X. Yang, Young Suk Kwon, Robert Timmerman, Raquibul Hannan   +3 more
doaj   +4 more sources

Adrenal oligometastasis cured with stereotactic ablative radiotherapy

Radiology Case Reports, 2020
Stereotactic ablative radiotherapy (SABR) has emerged as an effective, noninvasive alternative to surgery in patients with oligometastatic disease. Historically, select patients with adrenal oligometastases have been treated with adrenalectomies which ...
Julia Malone, BSC, Jason R. Pantarotto, MD FRCPC, David Tiberi, MD FRCPC, Shawn Malone, MD FRCPC   +3 more
doaj   +3 more sources

Bibliometric analysis of stereotactic ablative radiotherapy for oligometastases [PDF]

Frontiers in Medicine
BackgroundOligometastases, an intermediate stage of metastatic cancer, are increasingly managed with Stereotactic Ablative Radiotherapy (SABR), a highly precise local therapy representing a pivotal paradigm shift for improving patient outcomes.
Yupeng Di, Yupeng Di, Yupeng Di, Zhuo Song, Yingjie Wang, Lingling Meng, Jing Li, Jing Li   +7 more
doaj   +2 more sources

CyberKnife Stereotactic Ablative Radiotherapy for Lung Tumors

Technology in Cancer Research and Treatment, 2010
Stereotactic ablative radiotherapy (SABR) has emerged as a promising treatment for early stage non-small cell lung cancer, particularly for patients unable to tolerate surgical resection. High rates of local tumor control have been demonstrated with acceptable toxicity and the practical advantage of a short course of treatment.
Iris C Gibbs
exaly   +3 more sources

Organizing pneumonia after stereotactic ablative radiotherapy of the lung [PDF]

Radiation Oncology, 2012
Background Organizing pneumonia (OP), so called bronchiolitis obliterans organizing pneumonia after postoperative irradiation for breast cancer has been often reported. There is little information about OP after other radiation modalities.
Murai Taro, Shibamoto Yuta, Nishiyama Takeshi, Baba Fumiya, Miyakawa Akifumi, Ayakawa Shiho, Ogino Hiroyuki, Otsuka Shinya, Iwata Hiromitsu   +8 more
doaj   +3 more sources

Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors.

JAMA Oncol
ImportanceThe role of stereotactic ablative radiotherapy (SABR) for gynecologic malignant tumors has yet to be clearly defined despite recent clinical uptake.ObjectiveTo evaluate the outcomes of SABR in patients with oligometastatic and oligoprogressive gynecologic cancers.Design, Setting, and ParticipantsIn this retrospective pooled analysis, patients
Donovan EK, Lo SS, Beriwal S, Chen H, Cheung P, Keller A, Nwachukwu C, Mantz C, Pond GR, Schnarr K, Swaminath A, Albuquerque K, Leung E.   +12 more
europepmc   +3 more sources

Radiation and immunotherapy combinations in non-small cell lung cancer

Cancer Treatment and Research Communications, 2021
Non-small cell lung cancer (NSCLC) is a common and lethal malignancy. The recent development of immune checkpoint inhibitors has afforded a durable, dramatic treatment response for a subset of patients, but strategies to expand these benefits to a ...
Soheila Azghadi, Megan E. Daly
doaj   +1 more source

Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study. [PDF]

PLoS ONE, 2014
Stereotactic ablative radiotherapy is being increasingly adopted in the treatment of lung tumors. The use of proton beam therapy can further reduce dose to normal structures.
Benjamin Mou, Chris J Beltran, Sean S Park, Kenneth R Olivier, Keith M Furutani   +4 more
doaj   +1 more source